Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Breadcrumb
Home /
Guidelines
Written by:
HRS Conference, Radcliffe Cardiology
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
24 April 2024
Written by:
SCAI 2024, Radcliffe Cardiology
Featured Clinical Research to be Presented at SCAI 2024
24 April 2024
Written by:
EuroPCR 2024, Radcliffe Cardiology
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations
23 April 2024
Written by:
Heart Failure 2024, Radcliffe Cardiology
Late-Breaking Clinical Trial Presentations for Heart Failure Congress 2024 Revealed
23 April 2024
Written by:
Radcliffe Cardiology, Greg Guillory
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at…
10 April 2024
Written by:
Radcliffe Cardiology, Greg Guillory
Lerodalcibep, a Novel PCSK9, Achieves LDL Targets in 90% of Patients
07 April 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Full Results Following FDA Approval of AGENT Drug-Coated Balloon
20 March 2024
Written by:
Radcliffe Cardiology, Carrie Barclay; Special Editor: Greg Guillory
Semaglutide Produces Positive Kidney and CV Outcomes in the Flow Trial
19 March 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Increased Physical Activity Linked to Reduced Heart Failure Risk in Older Women
01 March 2024
Written by:
Radcliffe Cardiology, Carrie Barclay; Special Editor: Greg Guillory
Treatment Effect of NOAC Vs Wafarin in AF Shows Generally Consistent Stroke Rates Across the Spectrum of BMI…
29 February 2024
Written by:
EHRA 2024
European Heart Rhythm Association (EHRA) Congress 2024 Reveals its Late-Breaking Clinical Trial…
26 February 2024
Written by:
THT 2024
Technology and Heart Failure Therapeutics (THT) Conference Unveils its Late-Breaking Clinical Trial…
26 February 2024
Written by:
PAD Pulse Alliance
New Data: 70% of Americans Unaware of Common Vascular Disease That is One of the Leading Causes of…
19 February 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
09 February 2024
Written by:
Radcliffe Cardiology, Greg Guillory
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
06 February 2024
Written by:
ACC.24, Radcliffe Cardiology
American College of Cardiology Reveals its Late-Breaking Clinical Trial Presentations for 2024
30 January 2024
Written by:
Radcliffe Cardiology, Mirjam Boros; Special Editor: Greg Guillory
Apixaban Reduces Stroke Risk in Subclinical Atrial Fibrillation Compared to Aspirin at the Cost of Increased…
19 January 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Encouraging Top Line Results from ARISE-HF Phase III Study of AT-001 in Diabetic Cardiomyopathy
19 January 2024
Written by:
AF Symposium, Jordan Rance
The 29th Annual AF Symposium reveals its Late-Breaking Clinical Trial Presentations for 2024
09 January 2024
Written by:
CardioNerds for Radcliffe Cardiology
Dietary Modifications on Sodium Intake and The Impact on Blood Pressure
22 November 2023
Written by:
CardioNerds for Radcliffe Cardiology
Promising Breakthroughs in Lowering Lipoprotein(a) Levels with Lepodisiran: A Beacon of Hope for Patients…
22 November 2023
Written by:
AHA, Jordan Rance
AHA 2023 Late-Breaking Science Lineup Revealed
20 October 2023
Written by:
Radcliffe Cardiology
TCT 23: Late-Breaking Clinical Trials Revealed
19 October 2023
Written by:
Radcliffe Cardiology, Mirjam Boros
Language Matters: Guidelines for Talking about Obesity
19 October 2023